Peña-Asensio Julia, Sanz-de-Villalobos Eduardo, Miquel Joaquín, Larrubia Juan Ramón
Department of Systems Biology, Guadalajara University Hospital. University of Alcalá, Guadalajara E-19002, Guadalajara, Spain.
Translational Hepatology Unit, Guadalajara University Hospital, University of Alcalá, Guadalajara E-19002, Guadalajara, Spain.
World J Hepatol. 2020 Oct 27;12(10):754-765. doi: 10.4254/wjh.v12.i10.754.
Hepatitis C virus (HCV) infection is an excellent immunological model for understanding the mechanisms developed by non-cytopathic viruses and tumors to evade the adaptative immune response. The antigen-specific cytotoxic T cell response is essential for keeping HCV under control, but during persistent infection, these cells become exhausted or even deleted. The exhaustion process is progressive and depends on the infection duration and level of antigenemia. During high antigenic load and long duration of infection, T cells become extremely exhausted and ultimately disappear due to apoptosis. The development of exhaustion involves the impairment of positive co-stimulation induced by regulatory cytokines, such as transforming growth factor beta 1. This cytokine downregulates tumor necrosis factor receptor (TNFR)-associated factor 1 (TRAF1), the signal transducer of the T cell co-stimulatory molecule TNFR superfamily member 9 (known as 4-1BB). This impairment correlates with the low reactivity of T cells and an exhaustion phenotype. Treatment with interleukin-7 restores TRAF1 expression and rescues T cell effector function. The process of TRAF1 loss and its recovery is hierarchical, and more affected by severe disease progression. In conclusion, TRAF1 dynamics on T cells define a new pathogenic model that describes some aspects of the natural history of HCV, and sheds light on novel immunotherapy strategies for chronic viral infections and cancer.
丙型肝炎病毒(HCV)感染是理解非细胞病变病毒和肿瘤为逃避适应性免疫反应而形成的机制的优秀免疫模型。抗原特异性细胞毒性T细胞反应对于控制HCV至关重要,但在持续性感染期间,这些细胞会耗竭甚至缺失。耗竭过程是渐进性的,取决于感染持续时间和抗原血症水平。在高抗原负荷和长时间感染期间,T细胞会极度耗竭,最终因凋亡而消失。耗竭的发生涉及调节性细胞因子(如转化生长因子β1)诱导的正向共刺激受损。这种细胞因子下调肿瘤坏死因子受体(TNFR)相关因子1(TRAF1),而TRAF1是T细胞共刺激分子TNFR超家族成员9(称为4-1BB)的信号转导分子。这种损伤与T细胞的低反应性和耗竭表型相关。白细胞介素-7治疗可恢复TRAF1表达并挽救T细胞效应功能。TRAF1丢失及其恢复过程具有层次性,且受严重疾病进展的影响更大。总之,T细胞上TRAF1的动态变化定义了一种新的致病模型,该模型描述了HCV自然史的某些方面,并为慢性病毒感染和癌症的新型免疫治疗策略提供了线索。